Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov 18;58(5):2102527.
doi: 10.1183/13993003.02527-2021. Print 2021 Nov.

Success and continuous growth of the ERS clinical research collaborations

Affiliations
Free article
Editorial

Success and continuous growth of the ERS clinical research collaborations

Maarten van den Berge et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. van den Berge declares research grants (paid to institution) from GlaxoSmithKline, Roche, Genentech, Sanofi, AstraZeneca and Novartis, in the 36 months prior to manuscript submission. Conflict of interest: C. Genton is an employee of the European Respiratory Society. Conflict of interest: E. Heuvelin is an employee of the European Respiratory Society. Conflict of interest: A.K. Simonds has nothing to disclose. Conflict of interest: M. Humbert has nothing to disclose. Conflict of interest: A. Nyberg has nothing to disclose. Conflict of interest: R. Gosens declares research grants (paid to institution) from Aquilo, Sanofi-Genzyme and Boehringer Ingelheim, in the 36 months prior to manuscript submission. Conflict of interest: L. Donnelly has nothing to disclose. Conflict of interest: O. Fulton has nothing to disclose. Conflict of interest: M. Wilkens has nothing to disclose. Conflict of interest: N. Roche declares research grants (paid to institution) from GlaxoSmithKline, Boehringer Ingelheim, Pfizer and Novartis; consulting fees from Boehringer Ingelheim, Novartis, Pfizer, Teva, GlaxoSmithKline, AstraZeneca, Chiesi, Sanofi and Zambon; and honoraria for speaking or writing from Boehringer Ingelheim, Novartis, Pfizer, Teva, GlaxoSmithKline, AstraZeneca, Chiesi, Sanofi and Zambon, all in the 30 months prior to manuscript submission. Conflict of interest: C. Brightling has nothing to disclose.

Publication types

LinkOut - more resources